Objective: To assess the current microbiological profile and sensitivity to antibiotics in patients with acute bacterial prostatitis (ABP). Patients and Methods: In the period 2003–2010, we treated 192 ABP patients, aged from 18 to 85 years (average 56.3 years). We performed a biochemical examination including a microbiological urine examination. After admission, we immediately began the empirical antibacterial treatment. Results: The clinical picture was dominated by pain, prostate enlargement and failure of micturition in 185 (96.4%) patients; 14 (7.3%) patients had acute urinary retention where epicystostomy was necessary. Fever occurred in 177 (92.2%) patients and Escherichia coli was the most frequent etiological agent detected in 103 (53.7%) patients followed by Pseudomonas aeruginosa and Klebsiella species. In 16 (8.3%) patients we found 2 bacteriological strains. Sterile urine was found in 65 (33.8%) patients. Fluoroquinolones, aminoglycosides and cephalosporins were used most frequently. 147 (76.6%) patients were treated according to the microbiological results. Overview of resistance shows an increase in resistance to fluoroquinolones. In 14 (7.3%) patients there was progression to urosepsis. Conclusion: Clinicians should consider local drug-resistance patterns when choosing antibiotics and should adjust the therapy on the basis of bacterial cultures and local sensitivity to antibiotics.

Keywords:
Acute bacterial prostatitis, Microbial spectrum, Sensitivity to antibiotics
1.
Krieger JN, Lee SW, Jeon J, Cheah PY, Liong ML, Riley DE: Epidemiology of prostatitis. Int J Antimicrob Agents 2008;31(suppl 1): 585–590.
2.
Sharp VJ, Takacs EB, Powell CR: Prostatitis: diagnosis and treatment. Am Fam Physician 2010;82:397–406.
3.
Lipsky BA, Byren I, Hoey CT: Treatment of bacterial prostatitis. Clin Infect Dis 2010;50:1641–1652.
4.
Cunningham KA, Beagley KW: Male genital tract chlamydial infection: implications for pathology and infertility. Biol Reprod 2008;79:180–189.
5.
Etienne M, Chavanet P, Sibert L, Michel F, Levesque H, Lorcerie B, Doucet J, Pfitzenmeyer P, Caron F: Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect Dis 2008;8:12.
6.
Lee SJ, Lee DH, Park YY, Shim BS: A comparative study of clinical symptoms and treatment outcomes of acute bacterial prostatitis according to urine culture. Korean J Urol 2011;52:119–123.
7.
Ha US, Kim ME, Kim CS, Shim BS, Han CH, Lee SD, Cho YH: Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease. Int J Antimicrob Agents 2008;31(suppl 1):96–101.
8.
Etienne M, Pestel-Caron M, Chapuzet C, Bourgeois I, Chavanet P, Caron F: Should blood cultures be performed for patients with acute prostatitis? J Clin Microbiol 2010;48:1935–1938.
9.
Blango MG, Mulvey MA: Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 2010;54:1855–1863.
10.
Wagenlehner FM, Wullt B, Perletti G: Antimicrobials in urogenital infections. Int J Antimicrob Agents 2011;38(suppl):3–10.
11.
Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM: The diagnosis of urinary tract infection. Dtsch Arztebl Int 2010;107:361–367.
12.
Siriboon S, Tiengrim S, Taweemongkongsup T, Thamlikitkul V, Chayakulkeeree M: Prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided prostate biopsy in Thailand. Urol Int 2012;88:187–193.
13.
Yamamichi F, Shigemura K, Matsumoto M, Nakano Y, Tanaka K, Arakawa S, Fujisawa M: Relationship between urinary tract infection categorization and pathogens’ antimicrobial susceptibilities. Urol Int 2012;88:198–208.
14.
Torky M, Mosharafa A, Emran A, Kamal A, Abdelhamid M: Antimicrobial therapy for asymptomatic patients with elevated prostate-specific antigen: can the change in prostate-specific antigen reliably guide prostate biopsy decisions? Urol Int 2011;87:416–419.
15.
Pepe P, Aragona F: Does an inflammatory pattern at primary biopsy suggest a lower risk for prostate cancer at repeated saturation prostate biopsy? Urol Int 2011;87:171–174.
16.
Lee CB, Ha US, Yim SH, Lee HR, Sohn DW, Han CH, Cho YH: Does finasteride have a preventive effect on chronic bacterial prostatitis? Pilot study using an animal model. Urol Int 2011;86:204–209.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.